Academician
MUSTAFA KORKMAZ
ÖĞRETİM GÖREVLİSİ (Unvan:Doçent) (UYGULAMALI BİRİM)
SÜLEYMAN DEMİREL ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
A quick look at recorded outputs — details below.
- Articles 45
- Projects 0
- Books 0
- Proceedings 0
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
9
Q2
2
Q3
18
Q4
7
WoS (JCR)
Q1
2
Q2
5
Q3
8
Q4
18
TR Index
8
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
0
Avg percentile
11.9%
Top 1% share
0.0%
Top 10% share
0.0%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2025 Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy YÖKSİS SJR Q3 JCR Q4
- 2025 Tarlatamab in Small-Cell Lung Cancer YÖKSİS SJR Q1 JCR Q1
- 2025 Clinical Outcomes of Adjuvant Chemotherapy in Elderly Patients with Resected Stage II and III Colon Cancer: A Real-life Data YÖKSİS TR Index
- 2024 The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study YÖKSİS SJR Q1 JCR Q2
- 2024 Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma? YÖKSİS SJR Q2 JCR Q2 OpenAlex 21.1%
- 2024 Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study YÖKSİS SJR Q1 JCR Q2
- 2024 CN33 G-8 geriatric screening tool and geriatric nutritional risk index YÖKSİS SJR Q1 JCR Q1
- 2024 Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy YÖKSİS SJR Q3 JCR Q4
- 2024 Metastatik kolorektal kanserli hastalarda bevacizumab ile vücut kitle indeksi arasındaki ilişki YÖKSİS
- 2023 The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study YÖKSİS SJR Q1 JCR Q3
- 2023 Extensive metastatic ependymoma with long-term progression-free survival with capecitabine plus temozolomide combination chemotherapy: A case report YÖKSİS SJR Q3 JCR Q4
- 2023 Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study YÖKSİS SJR Q2 JCR Q3
- 2023 Sunitinib-induced small bowel wall edema as a prognostic marker in metastatic renal cell carcinoma YÖKSİS SJR Q3 JCR Q4
- 2023 Low-dose (7.5 mg/kg) bevacizumab may be a viable option in recurrent ovarian cancer: A retrospective study YÖKSİS SJR Q3 JCR Q4
- 2023 Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy? YÖKSİS SJR Q3 JCR Q4
- 2023 The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study YÖKSİS SJR Q1 JCR Q3
- 2023 A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score YÖKSİS TR Index
- 2023 A rare case of kidney loss: urogenital tuberculosis YÖKSİS SJR Q3
- 2023 A new prognostic factor in patients with recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan: Hemoglobin, albumin, lymphocytes and platelets (HALP) score YÖKSİS TR Index
- 2023 Otuz yaş altı meme kanserli kadınların klinikopatolojik özellikleri ve sağkalım sonuçları YÖKSİS TR Index